USCS News Alert Uscorp (USCS) 0.0014 10/01/2014 04:08:45

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Uscorp (USCS) 0.0014 $USCS

Audience to Host Fourth Quarter and Full Year 2013 Earnings Conference Call on February 6, 2014
Marketwire - Thu Jan 16, 3:05PM CST
Audience, Inc. (NASDAQ: ADNC), the leader in advanced voice and audio processing for mobile devices, today announced that it has scheduled a conference call for Thursday, February 6, 2014, at 1:30 p.m. PT / 4:30 p.m. ET to discuss its fourth quarter and full year 2013 financial results. Participating in the call will be Peter Santos, president and chief executive officer, and Kevin Palatnik, chief financial officer. Prepared remarks will be followed by a question and answer session.

USCorp's Subsidiary USMetals, Inc. Files S-1 Registration with the SEC
Business Wire - Thu Sep 12, 7:30AM CDT
USCorp (OTCMarkets: USCS.PK) today announced that its wholly owned subsidiary, USMetals, Inc., filed an S-1 Registration of USMetals' stock as part of the process of it spinning off from USCorp to become a standalone corporation and business.

USCorp Prepares for S-1 Registration of Spinoffs
Business Wire - Wed Jul 17, 7:30AM CDT
USCorp (OTCMarkets: USCS.PK) today announced that on July 16, 2013, USCorp withdrew the Form 10 Registration Statements filed on behalf of its subsidiaries, USMetals, Inc. and Imperial Metals, Inc., pursuant to the Securities Exchange Act of 1934.

USCorp Announces July 1, 2013 Record Date and Open Letter to Shareholders
Business Wire - Wed Jun 26, 7:30AM CDT
USCorp (OTCMarkets: USCS.PK) today announced the record date for spin offs: July 1, 2013. Shareholders of record on July 1 will receive one share of Imperial Metals, Inc. ("Imperial" and one share of USMetals, Inc. ("USMetals" for each 10 shares of USCorp owned at the close of business that day. USCorp is pleased to release the following open letter to its shareholders and to make this information available to the general public.

USCorp's Subsidiary Changes Name
Business Wire - Tue Jun 11, 7:30AM CDT
USCorp (OTCMarkets: USCS.PK) today announced the change of the name of USCorp's wholly owned subsidiary Southwest Resource Development, Inc., to Imperial Metals, Inc., and the increase in the authorized shares of Imperial Metals from 100,000,000 to 200,000,000 shares and the increase of the authorized shares of USMetals, Inc., from 75,000,000 to 200,000,000.

USCorp Announces Share Distribution Record Date
Business Wire - Tue Apr 09, 7:30AM CDT
USCorp (OTCMarkets: USCS.PK) today announced that the record date for distribution of shares of its subsidiaries, USMetals, Inc. ("USMetals" and Southwest Resource Development, Inc. ("Southwest" , will be market close on April 15, 2013. All holders of USCorp shares as of the April 15, 2013 record date will be entitled to receive one common share each of USMetals and Southwest for each 10 common shares (or shares convertible into common shares) held in USCorp.

USCorp Announces New High Grade Gold and Silver Ore Locations at Twin Peaks
Business Wire - Mon Mar 11, 3:15PM CDT
USCorp (OTCMarkets:USCS.PK) today announced that a new report describing the results of geological mapping carried out by the independent team of Quantum GeoConsultants Group, LLC ("Quantum" discovered visible gold and silver at widespread "hot areas" identified by satellite ASTER imagery and previously unexplored within the Twin Peaks project. In addition to newly discovered vein systems, some ore samples assayed over 4 ounces per ton of Gold, over 19 ounces per ton of silver, and over three ounces per ton of Palladium, 18% Titanium, and high amounts of rare earth metals.

USCorp Files Fiscal 2012 Annual and 2013 First Quarter Reports
Business Wire - Tue Feb 26, 7:30AM CST
USCorp (OTCMarkets: USCS.PK) today announced that it has filed its fiscal 2012 Annual Report and its fiscal 2013 First Quarter report with the SEC. USCorp believes this will make USMetals, Inc., and Southwest Resource Development, Inc., more attractive to potential merger, acquisition and/or joint-venture opportunities. These reports can be viewed at the Company's website at http://uscorpgold.com/financial-reporting/.

USCorp Announces Planned Spinoff of Subsidiaries and Share Distribution
Business Wire - Tue Feb 19, 7:30AM CST
USCorp (OTCMarkets: USCS.PK)(BCN: UCP.BE)(MUN: UCP.MU)(STU: U9CB.SG) today announced the Company is in the final stages of effecting the spinoff of its two wholly owned subsidiaries, USMetals, Inc. and Southwest Resource Development, Inc.

USCorp Completes First Step in Phase 4 Exploration at Twin Peaks Project
Business Wire - Fri Dec 21, 7:30AM CST
USCorp (OTCMarkets: USCS) today announced that it has completed the first step of its fourth phase of exploratory drilling at its Twin Peaks property in Yavapai County, Arizona. The drilling program is one that USCorp management believes will give us the results necessary for permitting the mine for production.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading